vs
Side-by-side financial comparison of BRC Inc. (BRCC) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.
BRC Inc. is the larger business by last-quarter revenue ($112.7M vs $57.3M, roughly 2.0× RHYTHM PHARMACEUTICALS, INC.). BRC Inc. runs the higher net margin — -2.8% vs -83.0%, a 80.1% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs 6.5%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs 7.0%).
BRC Inc., operating under the Black Rifle Coffee brand, is a U.S.-headquartered premium coffee and lifestyle brand. It sells roasted coffee beans, ready-to-drink coffee products, branded apparel, and outdoor gear, targeting primarily veteran, first responder, and outdoor enthusiast consumer segments across North America, via both e-commerce and physical retail channels.
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
BRCC vs RYTM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $112.7M | $57.3M |
| Net Profit | $-3.2M | $-47.5M |
| Gross Margin | 32.1% | 91.6% |
| Operating Margin | -6.3% | -82.2% |
| Net Margin | -2.8% | -83.0% |
| Revenue YoY | 6.5% | 36.9% |
| Net Profit YoY | -29.3% | -9.6% |
| EPS (diluted) | $-0.02 | $-0.73 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $112.7M | $57.3M | ||
| Q3 25 | $100.7M | $51.3M | ||
| Q2 25 | $94.8M | $48.5M | ||
| Q1 25 | $90.0M | $32.7M | ||
| Q4 24 | $105.9M | $41.8M | ||
| Q3 24 | $98.2M | $33.3M | ||
| Q2 24 | $89.0M | $29.1M | ||
| Q1 24 | $98.4M | $26.0M |
| Q4 25 | $-3.2M | $-47.5M | ||
| Q3 25 | $-486.0K | $-52.9M | ||
| Q2 25 | $-5.3M | $-46.6M | ||
| Q1 25 | $-2.9M | $-49.5M | ||
| Q4 24 | $-2.5M | $-43.3M | ||
| Q3 24 | $-535.0K | $-43.6M | ||
| Q2 24 | $-482.0K | $-32.3M | ||
| Q1 24 | $548.0K | $-141.4M |
| Q4 25 | 32.1% | 91.6% | ||
| Q3 25 | 36.9% | 89.3% | ||
| Q2 25 | 33.9% | 88.6% | ||
| Q1 25 | 36.1% | 88.8% | ||
| Q4 24 | 38.1% | 90.9% | ||
| Q3 24 | 42.1% | 88.5% | ||
| Q2 24 | 41.9% | 89.9% | ||
| Q1 24 | 42.9% | 89.2% |
| Q4 25 | -6.3% | -82.2% | ||
| Q3 25 | 0.5% | -102.6% | ||
| Q2 25 | -13.3% | -93.4% | ||
| Q1 25 | -6.0% | -143.7% | ||
| Q4 24 | -2.1% | -98.6% | ||
| Q3 24 | 1.1% | -132.0% | ||
| Q2 24 | 1.1% | -139.2% | ||
| Q1 24 | 4.0% | -538.7% |
| Q4 25 | -2.8% | -83.0% | ||
| Q3 25 | -0.5% | -103.1% | ||
| Q2 25 | -5.6% | -96.1% | ||
| Q1 25 | -3.2% | -151.4% | ||
| Q4 24 | -2.3% | -103.6% | ||
| Q3 24 | -0.5% | -131.2% | ||
| Q2 24 | -0.5% | -110.9% | ||
| Q1 24 | 0.6% | -544.4% |
| Q4 25 | $-0.02 | $-0.73 | ||
| Q3 25 | $0.00 | $-0.82 | ||
| Q2 25 | $-0.07 | $-0.75 | ||
| Q1 25 | $-0.04 | $-0.81 | ||
| Q4 24 | $-0.03 | $-0.71 | ||
| Q3 24 | $-0.01 | $-0.73 | ||
| Q2 24 | $-0.01 | $-0.55 | ||
| Q1 24 | $0.01 | $-2.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.3M | $388.9M |
| Total DebtLower is stronger | $34.7M | — |
| Stockholders' EquityBook value | $45.7M | $139.1M |
| Total Assets | $209.2M | $480.2M |
| Debt / EquityLower = less leverage | 0.76× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.3M | $388.9M | ||
| Q3 25 | $9.5M | $416.1M | ||
| Q2 25 | $4.3M | $291.0M | ||
| Q1 25 | $3.9M | $314.5M | ||
| Q4 24 | $6.8M | $320.6M | ||
| Q3 24 | $7.3M | $298.4M | ||
| Q2 24 | $9.6M | $319.1M | ||
| Q1 24 | $4.0M | $201.2M |
| Q4 25 | $34.7M | — | ||
| Q3 25 | $35.0M | — | ||
| Q2 25 | $72.7M | — | ||
| Q1 25 | $68.8M | — | ||
| Q4 24 | $65.1M | — | ||
| Q3 24 | $64.9M | — | ||
| Q2 24 | $66.5M | — | ||
| Q1 24 | $61.5M | — |
| Q4 25 | $45.7M | $139.1M | ||
| Q3 25 | $48.0M | $148.8M | ||
| Q2 25 | $10.1M | $-11.9M | ||
| Q1 25 | $11.2M | $18.9M | ||
| Q4 24 | $13.2M | $21.7M | ||
| Q3 24 | $14.5M | $11.2M | ||
| Q2 24 | $14.9M | $39.3M | ||
| Q1 24 | $14.6M | $61.6M |
| Q4 25 | $209.2M | $480.2M | ||
| Q3 25 | $222.4M | $506.9M | ||
| Q2 25 | $225.3M | $372.7M | ||
| Q1 25 | $222.9M | $386.7M | ||
| Q4 24 | $227.4M | $392.3M | ||
| Q3 24 | $233.7M | $363.6M | ||
| Q2 24 | $229.9M | $381.8M | ||
| Q1 24 | $227.2M | $258.7M |
| Q4 25 | 0.76× | — | ||
| Q3 25 | 0.73× | — | ||
| Q2 25 | 7.19× | — | ||
| Q1 25 | 6.15× | — | ||
| Q4 24 | 4.94× | — | ||
| Q3 24 | 4.47× | — | ||
| Q2 24 | 4.46× | — | ||
| Q1 24 | 4.21× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-8.7M | $-25.4M |
| Free Cash FlowOCF − Capex | $-9.4M | — |
| FCF MarginFCF / Revenue | -8.3% | — |
| Capex IntensityCapex / Revenue | 0.6% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-13.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-8.7M | $-25.4M | ||
| Q3 25 | $6.4M | $-26.6M | ||
| Q2 25 | $-3.3M | $-23.3M | ||
| Q1 25 | $-4.1M | $-40.4M | ||
| Q4 24 | $2.2M | $-18.8M | ||
| Q3 24 | $1.9M | $-25.2M | ||
| Q2 24 | $2.3M | $-29.1M | ||
| Q1 24 | $4.9M | $-40.7M |
| Q4 25 | $-9.4M | — | ||
| Q3 25 | $5.6M | — | ||
| Q2 25 | $-4.3M | — | ||
| Q1 25 | $-5.3M | — | ||
| Q4 24 | $504.0K | — | ||
| Q3 24 | $-205.0K | — | ||
| Q2 24 | $147.0K | — | ||
| Q1 24 | $2.2M | — |
| Q4 25 | -8.3% | — | ||
| Q3 25 | 5.5% | — | ||
| Q2 25 | -4.5% | — | ||
| Q1 25 | -5.9% | — | ||
| Q4 24 | 0.5% | — | ||
| Q3 24 | -0.2% | — | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | 2.2% | — |
| Q4 25 | 0.6% | — | ||
| Q3 25 | 0.8% | — | ||
| Q2 25 | 1.0% | — | ||
| Q1 25 | 1.3% | — | ||
| Q4 24 | 1.6% | — | ||
| Q3 24 | 2.2% | — | ||
| Q2 24 | 2.4% | — | ||
| Q1 24 | 2.8% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 8.97× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BRCC
| Sales Channel Through Intermediary | $72.9M | 65% |
| Sales Channel Directly To Consumer | $34.4M | 31% |
| Outpost | $5.4M | 5% |
RYTM
Segment breakdown not available.
